Pharma (multinational, EU-based)

pharma(multinational,eu-based

  • 3 FTE Chemists for 1 year
  • Medicinal Chemistry project: Design and synthesis of molecules for the treatment of Rheumatoid Arthritis (RA)
  • Involved at Lead Optimisation stage looking for compounds with the correct balance of potency/selectivity/physicochemical properties to progress to in vivo arthritis models and potentially further
  • Combination of singleton and parallel chemistry to facilitate rapid project progress
  • Flexible/rapid sharing of information via client confidential e-rooms and teleconferences
  • Charnwood Molecular seen as extension of in house project team by solving synthetic/medicinal chemistry problems in the series and offering medicinal chemistry ideas to client Project Leader
  • Project resourced further in-house by client after Charnwood Molecular’s successful involvement
  • Client poster featured at major EU conference

Related ProjectsYou might also be interested in these

Biotech (UK-based)

Rolling FTE contract (2 month blocks, 2 chemists) Patent expansion and customer assay Small focussed

Pharma (multinational, UK-based)

3 FTE Chemists for 3 years Extension to pharma’s project team Synthesis of novel active materials

Pharma (multinational, EU-based)

3 FTE Chemists for 1 year Medicinal Chemistry project: Design and synthesis of molecules for the

Biotechs (EU)

Average 6 month FTEs Three way collaboration: CM, CADS, Customer Assay Synthesis of analogues to:

Medical Research Institutes (US-based)

2 FTE Chemists for 1 year Lead optimisation antiviral project Route development to allow rapid